Literature DB >> 11083131

Use of melatonin in recovery from jet-lag following an eastward flight across 10 time-zones.

B J Edwards1, G Atkinson, J Waterhouse, T Reilly, R Godfrey, R Budgett.   

Abstract

Subjective, physiological and physical performance variables are affected following travel across multiple time-zones (jet-lag). The objective of the study was to examine the effects of oral melatonin in alleviating jet-lag by investigating its effects on subjects who had flown from London to Eastern Australia, 10 time-zones to the east. Melatonin (5 mg day(-1)) or placebo capsules were administered to 14 experimental (13 males and 1 female) and 17 control subjects (15 males and 2 females), respectively, in a double-blind study; the time of administration was in accord with the current consensus for maximizing its hypnotic effect. Grip strength and intra-aural temperature were measured on alternate days after arrival at the destination, at four different times of day (between the times 07:00 - 08:00 h, 12:00 - 13:00 h, 16:00 - 17:00 h and 19:00 - 20:00 h local time). In addition, for the first 6 - 7 days after arrival in Australia, subjective ratings of jet-lag on a 0 - 10 visual analogue scale and responses to a Jet-lag Questionnaire (incorporating items for tiredness. sleep, meal satisfaction and ability to concentrate) were recorded at the above times and also on retiring (at about midnight). Subjects continued normally with their work schedules between the data collection times. Subjects with complete data (13 melatonin and 13 placebo subjects), in comparison with published data, showed partial adjustment of the diurnal rhythm in intra-aural temperature after 6 days. A time-of-day effect was evident in both right and left grip strength during adjustment to Australian time; there was no difference between the group taking melatonin and that using the placebo. Right and left grip strength profiles on day 6 were adjusted either by advancing or delaying the profiles, independent of whether subjects were taking melatonin or placebo tablets. Subjects reported disturbances with most measures in the Jet-lag Questionnaire but, whereas poorer concentration and some negative effects upon sleep had disappeared after 3 - 5 days, ratings of jet-lag and tiredness had not returned to 'zero' (or normal values), respectively, by the sixth day of the study. Subjects taking melatonin showed no significant differences from the placebo group in perceived irritability, concentration, meal satisfaction, ease in getting to sleep and staying asleep, frequency of bowel motion and consistency of the faeces. These results suggest that, in subjects who, after arrival, followed a busy schedule which resulted in frequent and erratic exposure to daylight, melatonin had no benefit in alleviating jet-lag or the components of jet-lag, and it did not influence the process of phase adjustment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083131     DOI: 10.1080/001401300750003934

Source DB:  PubMed          Journal:  Ergonomics        ISSN: 0014-0139            Impact factor:   2.778


  15 in total

1.  The prevention and treatment of jet lag.

Authors:  Andrew Herxheimer; Jim Waterhouse
Journal:  BMJ       Date:  2003-02-08

Review 2.  How to trick mother nature into letting you fly around or stay up all night.

Authors:  Victoria L Revell; Charmane I Eastman
Journal:  J Biol Rhythms       Date:  2005-08       Impact factor: 3.182

3.  Jet lag: current and potential therapies.

Authors:  Mary Choy; Rebecca L Salbu
Journal:  P T       Date:  2011-04

4.  How To Travel the World Without Jet lag.

Authors:  Charmane I Eastman; Helen J Burgess
Journal:  Sleep Med Clin       Date:  2009-06-01

5.  Identifying some determinants of "jet lag" and its symptoms: a study of athletes and other travellers.

Authors:  J Waterhouse; B Edwards; A Nevill; S Carvalho; G Atkinson; P Buckley; T Reilly; R Godfrey; R Ramsay
Journal:  Br J Sports Med       Date:  2002-02       Impact factor: 13.800

6.  Circadian phase-shifting effects of repeated ramelteon administration in healthy adults.

Authors:  Gary S Richardson; Phyllis C Zee; Sherry Wang-Weigand; Laura Rodriguez; Xuejun Peng
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

Review 7.  Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis.

Authors:  Nina Buscemi; Ben Vandermeer; Nicola Hooton; Rena Pandya; Lisa Tjosvold; Lisa Hartling; Sunita Vohra; Terry P Klassen; Glen Baker
Journal:  BMJ       Date:  2006-02-10

Review 8.  Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.

Authors:  Timothy I Morgenthaler; Teofilo Lee-Chiong; Cathy Alessi; Leah Friedman; R Nisha Aurora; Brian Boehlecke; Terry Brown; Andrew L Chesson; Vishesh Kapur; Rama Maganti; Judith Owens; Jeffrey Pancer; Todd J Swick; Rochelle Zak
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 9.  Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 10.  The relevance of melatonin to sports medicine and science.

Authors:  Greg Atkinson; Barry Drust; Thomas Reilly; Jim Waterhouse
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.